recurrence

(redirected from recurrence risk)
Also found in: Dictionary, Medical, Legal, Encyclopedia.
Related to recurrence risk: Relative risk
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for recurrence

fresh outbreak

Synonyms for recurrence

a repeated occurrence

Synonyms for recurrence

happening again (especially at regular intervals)

References in periodicals archive ?
Prospective studies should be carried out to find out interventions that can significantly reduce the recurrence risk.
To check the robustness of our estimations, we develop an alternative measure of conflict recurrence risk without relying on the level and growth of domestic per capita income, presented in the second column of Table 1, and find that the estimated risk of conflict recurrence remains robust.
7) Women taking tamoxifen showed no difference in mortality or recurrence risk associated with soy intake.
Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment [published online ahead of print April 7, 2014].
This recurrence risk stratification system can provide promising guidance concerning the initial postoperative management of DTC, but it can also give rise to controversy.
Germinal mosaicism increases the recurrence risk for "new" Duchenne muscular dystrophy mutations.
Before folic acid fortification in the United States, the NTD recurrence risk was estimated to be about 2%-5% (3).
The recurrence risk for a woman who has had a single child with an NTD is 2-5% and increases if more than one child is affected.
This study showed good outcomes with recurrence risk reduction due to segmental resection, reliable mandibular reconstruction and less surgical procedures, allowing full rehabilitation within a shorter period of time and good esthetic and functional outcomes which improved quality of life.
two biomarkers for recurrence risk assessment - the molecular grade index, which measures expression levels of five genes related to tumor proliferation; and the H and I ratio, which compares expression levels of two other genes.
We used Student's t-test for the continuous variables with normal distribution, while the Mann-Whitney U-test was employed for the continuous variables outside the normal distribution between the ECV success and the recurrence risk of the atrial fibrillation groups.
Parents can be reassured that the recurrence risk for future pregnancies is low, as most affected individuals have de novo mutations.
Therefore the choice of adjuvant should be according to the environmental conditions, individual recurrence risk factors and the surgeon's expertise.